NCT06754644 2025-06-10A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLCQilu Pharmaceutical Co., Ltd.Phase 3 Recruiting808 enrolled
NCT03562871 2022-04-21IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLCIO BiotechPhase 1/2 Completed109 enrolled